Log in to save to my catalogue

Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarker...

Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarker...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1878182950

Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy

About this item

Full title

Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy

Publisher

Dordrecht: Springer Netherlands

Journal title

International ophthalmology, 2018-04, Vol.38 (2), p.607-615

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

Background/Aims
Glyceraldehyde-derived advanced glycation end products (glycer-AGE; also called Toxic-AGE [TAGE]) play a crucial role in the pathogenesis of diabetic angiopathy. However, the relationships between vitreous glycer-AGE levels and diabetic retinopathy (DR) severity, and between glycer-AGE levels and the levels of other angiogenic fa...

Alternative Titles

Full title

Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1878182950

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1878182950

Other Identifiers

ISSN

0165-5701

E-ISSN

1573-2630

DOI

10.1007/s10792-017-0499-1

How to access this item